SEC receives amended S-1/A filing for 21Shares Injective ETF
The U.S. Securities and Exchange Commission (SEC) has received an amended S-1/A filing for the 21Shares Injective ETF. This development in the altcoin ETF race could potentially accelerate mainstream adoption of altcoins and influence market dynamics and investor strategies.
Summaries are written by AI from the original article. Not investment advice.